TMRW Life Sciences has created the first automated solution for how frozen eggs and embryos are stored, tracked, and monitored during the IVF process. Before TMRW, these irreplaceable eggs and embryos were solely managed using manual and analog methods borrowed from livestock breeding, leaving eggs and embryos vulnerable to significant human error. TMRW's technology brings the IVF lab into the 21st century and ushers in a new standard of care for eggs and embryos just as fertility care has reached an inflection point: It's estimated that 15% of couples worldwide now struggle with infertility. The outdated systems clinics have put in place are simply incapable of meeting this rising demand for IVF and egg freezing. With the TMRW platform, eggs and embryos are traceable using RFID technology and safely maintained at cryogenic temperatures using robotics, 24/7 remote monitoring, and fully integrated software. The TMRW platform is transforming the possibilities for fertility and family planning by safeguarding the most precious cells for life.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/20/21 | $105,000,000 | Series C |
5AM Ventures Anne Wojcicki Casdin Capital GV Life Sciences Innovation Fund Peter Thiel Susan Wojcicki Transformation Capital  | undisclosed |
